Episode Details
Back to Episodes
Who Should Get Visual Field Testing? A Population-Based Framework
Description
This audio article is from VisualFieldTest.com.
Read the full article here: https://visualfieldtest.com/en/who-should-get-visual-field-testing-a-population-based-framework
Test your visual field online: https://visualfieldtest.com
Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support
Excerpt:
Who Should Get Visual Field Testing? A Population-Based Framework Visual field testing measures how well a person sees across the central and peripheral parts of the visual field. It is especially important because many eye and brain disorders damage peripheral vision gradually, without causing obvious symptoms at first. However, routine visual field testing is not necessary for every healthy, asymptomatic adult. The highest value comes from testing people whose examination, medical history, medication use, or disease pattern creates a meaningful risk of developing or worsening field loss. This targeted approach helps detect silent damage while limiting false-positive results, unnecessary anxiety, and avoidable testing. What Visual Field Testing Detects Most clinical visual field tests use automated static threshold perimetry. One eye is tested at a time while the patient looks at a central target and presses a button whenever a spot of light is seen. The test can identify: Peripheral blind spots caused by glaucoma Central or paracentral defects affecting reading or fixation Bitemporal defects associated with pituitary or other chiasmal disease Altitudinal defects associated with ischemic optic neuropathy Enlargement of the blind spot associated with papilledema Concentric peripheral loss caused by some toxic retinal disorders Hemifield loss after stroke or damage to the visual pathways Visual field testing is different from a visual acuity test. A person may still read the eye chart well while having important peripheral field loss. The two eyes also overlap, allowing one eye to compensate for defects in the other. Because visual field testing depends on attention, learning, fatigue, and response consistency, one abnormal result should usually be confirmed unless the pattern is clearly urgent. National Institute for Health and Care Excellence glaucoma guideline () The Population-Based Principle: Targeted Testing Rather Than Universal Screening The United States Preventive Services Task Force has found insufficient evidence to recommend routine population-wide screening for primary open-angle glaucoma in asymptomatic adults. This does not mean that visual field testing is unhelpful. Rather, it means that testing is more useful when directed toward people with identifiable risk factors or suspicious findings. United States Preventive Services Task Force recommendation () A comprehensive eye examination is still important, particularly as people get older or develop medical risk factors. The American Academy of Ophthalmology recommends a baseline comprehensive eye examination around age 40, with follow-up based on individual risk. Visual field testing should then be added when there is a suspicious optic nerve, elevated intraocular pressure, a relevant medication exposure, visual symptoms, or a disorder affecting the optic nerve or brain. American Academy of Ophthalmology glaucoma screening information () The groups most likely to benefit from routine or repeated testing are: Glaucoma suspects People with ocular hypertension People with established glaucoma Patients with neuro-ophthalmic disease Patients taking medications that can injure the retina or optic nerve Evidence on Asymptomatic Visual Field Loss Glaucoma may be advanced before a patient notices it Glaucoma usually develops slowly. Early defects often occur outside th